Initial Efforts toward the Optimization of Arylomycins for Antibiotic Activity
- 28 June 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 54 (14), 4954-4963
- https://doi.org/10.1021/jm1016126
Abstract
While most clinically used antibiotics were derived from natural products, the isolation of new broad-spectrum natural products has become increasingly rare and narrow-spectrum agents are typically deemed unsuitable for development because of intrinsic limitations of their scaffold or target. However, it is possible that the spectrum of a natural product antibiotic might be limited by specific resistance mechanisms in some bacteria, such as target mutations, and the spectra of such "latent" antibiotics might be reoptimized by derivatization, just as has been done with clinically deployed antibiotics. We recently showed that the spectrum of the arylomycin natural product antibiotics, which act via the novel mechanism of inhibiting type I signal peptidase, is broader than previously believed and that resistance in several key human pathogens is due to the presence of a specific Pro residue in the target peptidase that disrupts interactions with the lipopeptide tail of the antibiotic. To begin to test whether this natural resistance might be overcome by derivatization, we synthesized analogues with altered lipopeptide tails and identified several with an increased spectrum of activity against S. aureus. The data support the hypothesis that the arylomycins are latent antibiotics, suggest that their spectrum may be optimized by derivatization, and identify a promising scaffold upon which future optimization efforts might focus.Keywords
This publication has 64 references indexed in Scilit:
- Broad-Spectrum Antibiotic Activity of the Arylomycin Natural Products Is Masked by Natural Target MutationsCell Chemical Biology, 2010
- Crystallographic Analysis of Bacterial Signal Peptidase in Ternary Complex with Arylomycin A2 and a β-Sultam InhibitorBiochemistry, 2009
- Structure, membrane orientation, mechanism, and function of pexiganan — A highly potent antimicrobial peptide designed from magaininBiochimica et Biophysica Acta (BBA) - Biomembranes, 2009
- The role of natural environments in the evolution of resistance traits in pathogenic bacteriaProceedings Of The Royal Society B-Biological Sciences, 2009
- Hydrophobic Side-Chain Length Determines Activity and Conformational Heterogeneity of a Vancomycin Derivative Bound to the Cell Wall of Staphylococcus aureusBiochemistry, 2008
- The frailty of adaptive hypotheses for the origins of organismal complexityProceedings of the National Academy of Sciences of the United States of America, 2007
- Marcel Faber Roundtable: Is our antibiotic pipeline unproductive because of starvation, constipation or lack of inspiration?Journal of Industrial Microbiology & Biotechnology, 2006
- Pseudomonas aeruginosa Synthesizes Phosphatidylcholine by Use of the Phosphatidylcholine Synthase PathwayJournal of Bacteriology, 2002
- Natural Products in Drug Discovery and DevelopmentJournal of Natural Products, 1997
- On the size of the active site in proteases. I. PapainBiochemical and Biophysical Research Communications, 1967